This article links to Jenny Chen’s recent LinkedIn Posting where she grouped both public and private bioprinting companies to four: Newborns, Warriors, Unicorns, and Winners. The posting has spurred lively discussion in our 3D printing space. Jenny says she did this as a fun exercise and reminds that the grouping isn’t a stock buy/sell suggestion. We at Brinter feel that she positioned Brinter properly in the Newborns.
About Jenny Chen, MD
Jenny is the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. She is trained as a neuroradiologist, Dr. Chen holds degrees in both medicine and radiology from the David Geffen School of Medicine at UCLA and completed fellowship training in neuroradiology at Harvard Medical School.She currently serves as Adjunct Clinical Faculty in neuroradiology at Stanford University Medical Center. With a focus on health technology, Dr. Chen also serves as a startup Mentor to IndieBio EU and French Tech Hub, tech accelerators that help IT and life science companies launch and expand their product offerings, identify customers, and manage operations. Her interests lie in the applications of emerging technologies (especially in the field of 3D printing and bioprinting), automated biology, and has a vision of decentralized and personalized healthcare delivery system for our near future.
